ArticleBlood advances2023

Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy.

Evandro D Bezerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.